Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00969410
What this trial is testing

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

Who this might be right for
Malignant Solid TumourLiver Metastases
AVEO Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175636
What this trial is testing

QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Mismatch Repair-Proficient (pMMR) Rectal CancerNon-metastatic Rectal Cancer
Sun Yat-sen University 66
Testing effectiveness (Phase 2)Ended earlyNCT00323011
What this trial is testing

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Southern California 5
Early research (Phase 1)Study completedNCT06131398
What this trial is testing

AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT02711553
What this trial is testing

Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerMetastatic CancerAdvanced Cancer
Eli Lilly and Company 309
Testing effectiveness (Phase 2)Looking for participantsNCT06799637
What this trial is testing

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Who this might be right for
Advanced Solid TumorsPancreatic CarcinomaOvarian Cancer+1 more
Evopoint Biosciences Inc. 350
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Early research (Phase 1)Study completedNCT00536809
What this trial is testing

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

Who this might be right for
Neoplasms, Colorectal
GlaxoSmithKline 12
Testing effectiveness (Phase 2)UnknownNCT05417230
What this trial is testing

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

Who this might be right for
Biliary Tract Cancer
Jiangsu Cancer Institute & Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02414009
What this trial is testing

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 82
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Testing effectiveness (Phase 2)Looking for participantsNCT06532799
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

Who this might be right for
Stomach CancerStomach Cancer RecurrentStomach Cancer, Adenocarcinoma+4 more
Essen Biotech 75
Early research (Phase 1)Ended earlyNCT01086332
What this trial is testing

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Iowa 7
Testing effectiveness (Phase 2)WithdrawnNCT03509298
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT04294498
What this trial is testing

Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection

Who this might be right for
Advanced Hepatocellular Carcinoma
National Taiwan University Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06709144
What this trial is testing

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

Who this might be right for
Colon Cancer
Haixing Ju, MD 896
Testing effectiveness (Phase 2)Study completedNCT02271464
What this trial is testing

Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 232
Testing effectiveness (Phase 2)Looking for participantsNCT07042685
What this trial is testing

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)
The Methodist Hospital Research Institute 50
Next Page